Rabanes, Mary Mae O.
HRN: 23-06-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2023
CEFTRIAXONE 1G (VIAL)
05/17/2023
05/23/2023
IV
2g
Q24H
Acute Uncomplicated Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes